Prior to Act 290, a pharmacist or pharmacist intern could only administer an injectable prescribed drug product or device in the course of teaching self-administration techniques to a patient. Act 290 removes the restriction for the purposes of patient teaching only. The proposed rule would update the requirements and procedures to reflect the statutory change.
4. Detailed explanation of statutory authority for the rule (including the statutory citation and language):
s. 15.08 (5) (b), Stats. Each examining board: shall promulgate rules for its own guidance and for the guidance of the trade or profession to which it pertains and define and enforce professional conduct and unethical practices not inconsistent with the law relating to the particular trade or profession. s. 450.02 (2g) (b), Stats. The board shall promulgate rules that establish requirements and procedures for the administration of a drug product or device, as defined in s. 450.035(1g), by a pharmacist under s. 450.035 (1r). 5. Estimate of amount of time that state employees will spend developing the rule and of other resources necessary to develop the rule:
75 hours
6. List with description of all entities that may be affected by the proposed rule:
Pharmacists, pharmacist interns, and patients.
7. Summary and preliminary comparison with any existing or proposed federal regulation that is intended to address the activities to be regulated by the proposed rule:
None
8. Anticipated economic impact of implementing the rule (note if the rule is likely to have a significant economic impact on small businesses):
None to minimal. It is not likely to have a significant economic impact on small businesses.
Contact Person: Sharon Henes, Administrative Rules Coordinator, (608) 261-2377
